Restoring the function of pathogenic PINK1 mutations found in Parkinson’s patients with small molecule drugs, is a paradigm shift in Parkinson’s disease.

Misbehaving T cells light up long before Parkinson’s symptoms show, zeroing in on vulnerable brain proteins. Their early ...

Your T cells work hard to fight disease. Unfortunately, "friendly fire" from T cells can sometimes harm the body's healthy tissues.

Bangladeshi-origin neurologist Miratul Muqit has been appointed as the inaugural director of the United Kingdom's National ...

Progenra Inc. reports that it has discovered a new class of small-molecule PINK1 activators that restore function in mutant forms of the PINK1 kinase, a key mitochondrial regulator whose dysfunction ...

A University of Dundee expert has been appointed to lead a new centre that will drive research to better understand the ...

Parkinson's disease occurs when brain cells that produce an important hormone called dopamine begin to die off or become ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Inactivating mutations in human Parkin, a ubiquitin E3 ligase and PINK1, a kinase, genes present a significant population of inherited Parkinson’s disease.